Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on FcRn-blocking therapies in neurology!
Andrea Rossetti, MD, director of the EEG/Epilepsy Unit at the Department of Clinical Neurosciences the Lausanne University Hospital in Switzerland, offers insight into post-resuscitation epilepsy care.
Here's some of what is coming soon to NeurologyLive® this week.
Orelabrutinib Achieves Primary Endpoint in Phase 2b SLE Trial
Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal
Phase 3 VALIANT Results for Pegcetacoplan In C3G, IC-MPGN, With Andrew Bomback, MD
Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible
1.
An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.
2.
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL
3.
Extracellular matrix pathway emerges as treatment target for pediatric cancer
4.
Are ultramarathon runners really at increased risk of bowel cancer?
5.
Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.
1.
Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources
2.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
3.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Exploring Innovative Solutions for Infantile Hemangioma Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
2.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
3.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge